BACKGROUND: Simulation modeling can synthesize data from single-arm studies of lung cancer screening and tumor registries to investigate computed tomography (CT) screening. This study estimated changes in lung cancer outcomes through 2005, had chest CT screening been introduced in 1990. METHODS: Hypothetical individuals with smoking histories representative of 6 US cohorts (white males and females aged 50, 60, and 70 years in 1990) were simulated in the Lung Cancer Policy Model, a comprehensive patient-level simulation model of lung cancer development, screening, and treatment. A no screening scenario corresponded to observed outcomes. We simulated 3 screening scenarios in current or former smokers with > or =20 pack-years as follows: 1-time screen in 1990; and annual, and twice-annually screenings beginning in 1990 and ending in 2005. Main outcomes were days of life between 1990 and 2005 and life expectancy in 1990 (estimated by simulating life histories past 2005). RESULTS: All screening scenarios yielded reductions (compared with no screening) in lung cancer-specific mortality by 2005, with larger reductions predicted for more frequent screening. Compared with no screening, annual screening of ever-smokers with at least 20 pack-years of cigarette exposure provided ever-smokers with an additional 11 to 33 days of life by 2005, or an additional 3-10 weeks of (undiscounted) life expectancy. In sensitivity analyses, the largest effects on gains from annual screening were due to reductions in screening adherence and increased smoking cessation. CONCLUSIONS: The adoption of CT screening, had it been available in 1990, might have resulted in a modest gain in life expectancy.
BACKGROUND: Simulation modeling can synthesize data from single-arm studies of lung cancer screening and tumor registries to investigate computed tomography (CT) screening. This study estimated changes in lung cancer outcomes through 2005, had chest CT screening been introduced in 1990. METHODS: Hypothetical individuals with smoking histories representative of 6 US cohorts (white males and females aged 50, 60, and 70 years in 1990) were simulated in the Lung Cancer Policy Model, a comprehensive patient-level simulation model of lung cancer development, screening, and treatment. A no screening scenario corresponded to observed outcomes. We simulated 3 screening scenarios in current or former smokers with > or =20 pack-years as follows: 1-time screen in 1990; and annual, and twice-annually screenings beginning in 1990 and ending in 2005. Main outcomes were days of life between 1990 and 2005 and life expectancy in 1990 (estimated by simulating life histories past 2005). RESULTS: All screening scenarios yielded reductions (compared with no screening) in lung cancer-specific mortality by 2005, with larger reductions predicted for more frequent screening. Compared with no screening, annual screening of ever-smokers with at least 20 pack-years of cigarette exposure provided ever-smokers with an additional 11 to 33 days of life by 2005, or an additional 3-10 weeks of (undiscounted) life expectancy. In sensitivity analyses, the largest effects on gains from annual screening were due to reductions in screening adherence and increased smoking cessation. CONCLUSIONS: The adoption of CT screening, had it been available in 1990, might have resulted in a modest gain in life expectancy.
Authors: Pamela M McMahon; Chung Yin Kong; Bruce E Johnson; Milton C Weinstein; Jane C Weeks; Karen M Kuntz; Jo-Anne O Shepard; Stephen J Swensen; G Scott Gazelle Journal: Radiology Date: 2008-05-05 Impact factor: 11.105
Authors: John K Gohagan; Pamela M Marcus; Richard M Fagerstrom; Paul F Pinsky; Barnett S Kramer; Philip C Prorok; Susan Ascher; William Bailey; Brenda Brewer; Timothy Church; Deborah Engelhard; Melissa Ford; Mona Fouad; Matthew Freedman; Edward Gelmann; David Gierada; William Hocking; Subbarao Inampudi; Brian Irons; Christine Cole Johnson; Arthur Jones; Gena Kucera; Paul Kvale; Karen Lappe; William Manor; Alisha Moore; Hrudaya Nath; Sarah Neff; Martin Oken; Michael Plunkett; Helen Price; Douglas Reding; Thomas Riley; Martin Schwartz; David Spizarny; Roberta Yoffie; Carl Zylak Journal: Lung Cancer Date: 2005-01 Impact factor: 5.705
Authors: Heather A Wakelee; Ellen T Chang; Scarlett L Gomez; Theresa H Keegan; Diane Feskanich; Christina A Clarke; Lars Holmberg; Lee C Yong; Laurence N Kolonel; Michael K Gould; Dee W West Journal: J Clin Oncol Date: 2007-02-10 Impact factor: 44.544
Authors: Tazio Vanni; Jonathan Karnon; Jason Madan; Richard G White; W John Edmunds; Anna M Foss; Rosa Legood Journal: Pharmacoeconomics Date: 2011-01 Impact factor: 4.981
Authors: William D Travis; Elisabeth Brambilla; Masayuki Noguchi; Andrew G Nicholson; Kim R Geisinger; Yasushi Yatabe; David G Beer; Charles A Powell; Gregory J Riely; Paul E Van Schil; Kavita Garg; John H M Austin; Hisao Asamura; Valerie W Rusch; Fred R Hirsch; Giorgio Scagliotti; Tetsuya Mitsudomi; Rudolf M Huber; Yuichi Ishikawa; James Jett; Montserrat Sanchez-Cespedes; Jean-Paul Sculier; Takashi Takahashi; Masahiro Tsuboi; Johan Vansteenkiste; Ignacio Wistuba; Pan-Chyr Yang; Denise Aberle; Christian Brambilla; Douglas Flieder; Wilbur Franklin; Adi Gazdar; Michael Gould; Philip Hasleton; Douglas Henderson; Bruce Johnson; David Johnson; Keith Kerr; Keiko Kuriyama; Jin Soo Lee; Vincent A Miller; Iver Petersen; Victor Roggli; Rafael Rosell; Nagahiro Saijo; Erik Thunnissen; Ming Tsao; David Yankelewitz Journal: J Thorac Oncol Date: 2011-02 Impact factor: 15.609
Authors: Kathryn P Lowry; G Scott Gazelle; Michael E Gilmore; Colden Johanson; Vidit Munshi; Sung Eun Choi; Angela C Tramontano; Chung Yin Kong; Pamela M McMahon Journal: Cancer Date: 2015-02-03 Impact factor: 6.860
Authors: Angela C Tramontano; Lauren E Cipriano; Chung Yin Kong; Jo-Anne O Shepard; Michael Lanuti; G Scott Gazelle; Pamela M McMahon Journal: AJR Am J Roentgenol Date: 2013-05 Impact factor: 3.959
Authors: Pamela M McMahon; Chung Yin Kong; Bruce E Johnson; Milton C Weinstein; Jane C Weeks; Angela C Tramontano; Lauren E Cipriano; Colleen Bouzan; G Scott Gazelle Journal: Risk Anal Date: 2012-07 Impact factor: 4.000
Authors: Jihyoun Jeon; Theodore R Holford; David T Levy; Eric J Feuer; Pianpian Cao; Jamie Tam; Lauren Clarke; John Clarke; Chung Yin Kong; Rafael Meza Journal: Ann Intern Med Date: 2018-10-09 Impact factor: 25.391